ZS PHARMA INC's ticker is ZSPH and the CUSIP is 98979G105. A total of 78 filers reported holding ZS PHARMA INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,013,000 | +23.9% | 61,120 | -1.2% | 0.01% | +25.0% |
| Q2 2015 | $3,240,000 | +301.5% | 61,847 | +222.6% | 0.00% | +300.0% |
| Q1 2015 | $807,000 | +4.4% | 19,171 | +3.0% | 0.00% | 0.0% |
| Q4 2014 | $773,000 | +6.5% | 18,604 | +0.5% | 0.00% | 0.0% |
| Q3 2014 | $726,000 | – | 18,507 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 2,576,723 | $108,429,000 | 79.85% |
| Ghost Tree Capital, LLC | 330,000 | $13,886,000 | 2.50% |
| RA Capital Management | 564,483 | $23,753,000 | 2.36% |
| Monashee Investment Management LLC | 60,000 | $2,525,000 | 1.57% |
| Redmile Group, LLC | 405,688 | $17,071,000 | 1.53% |
| Opaleye Management Inc. | 75,000 | $3,156,000 | 1.46% |
| Partner Investment Management, L.P. | 22,047 | $928,000 | 1.40% |
| RTW INVESTMENTS, LP | 71,315 | $3,001,000 | 1.36% |
| DAFNA Capital Management LLC | 39,100 | $1,645,000 | 1.26% |
| PFM Health Sciences, LP | 884,575 | $37,223,000 | 1.03% |